| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d0f1a2212e60d1c56c39101d9eecb75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d12b35c0dd9adfb167b3b4f383afe93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-17 |
| filingDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_704264609a33686636bd2400deffd1e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83dd4f972fcbb1c83731681a07cfadae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef3dd6e20065191b575559b785eaa59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08767c22c15c9dc0971f9d030b4251a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd66129d87010c832706ed6ff037420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2b48da6d757001e6ce71b4115d88cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b033203e372d0846b74b8dbafc8d8d80 |
| publicationDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2372391-B1 |
| titleOfInvention |
METHOD OF DIAGNOSIS OF THE DISEASE OF FARBER. |
| abstract |
Diagnostic method of Farber's disease. # The present invention relates to a family of compounds with a structural nucleus of amino alcohol derivatives and their use for the detection of Farber's disease by applying a diagnostic method outside the human body in the that said compounds bound to a fluorophore, chromophore or luminophore are used as substrates for the enzyme ceramidase acid, whose functionality is diminished in patients with said disease. In addition the present invention relates to a kit comprising at least one of these compounds for use in the diagnosis of the disease from an isolated biological sample of an individual. |
| priorityDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |